BioSpace News Archive

BioMidwest

HVR CARDIO CLOSES ON $11 Million SERIES B FINANCING WITH FINLAND’S INNOVESTOR LIFE SCIENCE FUND AND TESI

HVR Cardio, a clinical stage medical technology company developing Structural Heart cardiovascular products for transcatheter mitral valve repair, announced today that it has closed on its 10.7 million Euro ($11.1M US) Series B Round of financing.

January 12, 2023
·
2 min read
Genetown

Aitia and G3 Therapeutics Publish Results Identifying New Causal Biomarkers of Atherosclerotic Coronary Artery Disease (ASCAD), the Leading Cause of Morbidity and Mortality Worldwide

G3 Therapeutics and Aitia, the leader in the application of Causal AI and “Digital Twins” to discover and develop new drugs, today announced results of research that identified new causes of ASCAD.

January 12, 2023
·
5 min read
Revive Therapeutics To Submit Updated Briefing Package in Support of Upcoming Type C Meeting Granted by FDA for Amended Protocol Agreement of Phase 3 Clinical Study for Bucillamine in the Treatment of COVID-19

Revive Therapeutics Ltd. announces it will submit an updated briefing package to the U.S. Food & Drug Administration (“FDA”) to include additional supporting information and the data from the independent published study, titled “Omicron Spike Protein Is Vulnerable to Reduction” from the University of Toronto.

January 12, 2023
·
3 min read
Pharm Country

MEDSCAPE SURVEY FINDS REASONS PAXLOVID IS UNDERPRESCRIBED FOR THOSE 65 AND OLDER, DESPITE ITS EFFECTIVENESS AGAINST COVID COMPLICATIONS

Paxlovid (nirmatrelvir with ritonavir) has been shown in clinical studies to be a highly-effective treatment to mitigate the severity of a COVID-19 infection—with some studies showing it can be close to 90% effective in reducing the risk of severe disease, and in reducing hospitalization for people age 65 and over.

January 12, 2023
·
3 min read
Biotech Bay

Terns Pharmaceuticals to Present at B. Riley Securities’ 3rd Annual Oncology Conference

Terns Pharmaceuticals, Inc. today announced that management will participate in a fireside chat at the B. Riley Securities 3rd Annual Oncology Conference on Wednesday, January 18, 2023 at 2:30 p.m.

January 12, 2023
·
1 min read
Business

IsoPlexis Reports Preliminary Full Year 2022 Revenue

IsoPlexis Corporation today announced its preliminary unaudited revenue for the full year ended December 31, 2022.

January 12, 2023
·
10 min read
BioCapital

Gain Therapeutics to Present at Sidoti Small-Cap Virtual Investor Conference

Gain Therapeutics, Inc. will present a corporate update at the Sidoti Small-Cap Virtual Investor Conference on Wednesday, January 18 at 2:30 PM ET.

January 12, 2023
·
4 min read
Biotech Beach

Biolase Receives Top Workplaces 2022 Award

BIOLASE, Inc., the global leader in dental lasers, announced that the Company has been awarded a Top Workplaces 2022 honor by the Orange County Register Top Workplaces.

January 12, 2023
·
4 min read
Silence Therapeutics Provides SLN360 and SLN124 Clinical Program Updates

Silence Therapeutics plc today provided the following SLN360 and SLN124 program updates during a presentation at the 41st Annual J.P. Morgan Healthcare Conference.

January 12, 2023
·
4 min read
Business

Mr. David Gryska Appointed to Forte Biosciences Board of Directors

Forte Biosciences, Inc. ( www.fortebiorx.com ) (NASDAQ: FBRX), announced today that Mr. David Gryska has been appointed to the Forte Biosciences Board of Directors.

January 12, 2023
·
4 min read